CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Group Investor Call15-11-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Group Investor CallZydus Cadila's COVID vaccine to be administered only to adults as of now: Report
Union Health Minister Mansukh Mandaviya on Thursday said the government does not want to make haste about administering COVID vaccines to children and any decision in this regard will be taken based on expert opinion.Govt to buy 1 crore doses of Zydus Cadila's Covid shot at 265 each
The three-dose vaccine, ZyCoV-D, was approved by the country's drug regulator in August for emergency use in adults and children aged 12 years and above.Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated November 12, 2021 titled 'Zydus Cadila receives tentative approval from USFDA for Eluxadoline Tablets'Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated November 10, 2021 titled 'Zydus Cadila receives final approval from USFDA for Glycopyrrolate Injection'Zydus Cadila to supply 1 crore doses of COVID-19 vaccine ZyCoV-D to Indian govt
ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above. The three doses of ZyCoV-D are to be administered 28 days apart.CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated November 8, 2021 titled 'Cadila Healthcare Ltd., to supply 1 crore doses of ZyCoV-D, the world's first Plasmid DNA vaccine to the Government of India'Centre places order for 1mn doses of Zydus Cadila's needle-free Covid vax
ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above.Cadila: Unfolding vaccine opportunity can offset US headwinds
For a longer term play, Cadila has a promising pipeline for NCEs (New chemical entities), biosimilars and injectablesCADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting with regard to publication of extracts of unaudited financial results for the quarter/ half year ended on September 30, 2021